Clinical predictors associated with duration of repetitive transcranial magnetic stimulation treatment for remission in bipolar depression: A naturalistic study

Journal of Nervous and Mental Disease

Volumn 198, Issue 9, 2010, Pages 679-681

  Cohen, Roni B ^a   Brunoni, Andre R ^b   Boggio, Paulo S ^c   Fregni, Felipe ^b,d  

^a Centro Brasileiro de Estimulacao Magnetica Transcraniana   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c MACKENZIE PRESBYTERIAN UNIVERSITY   (Brazil)

^d and Red Sox Foundation and Massachusetts General Hospital Home Base Program   (United States)

Author keywords

Bipolar disorder; clinical trial; major depressive disorder; predictors of response; repetitive transcranial magnetic stimulation

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; ESCITALOPRAM; LAMOTRIGINE; LITHIUM; MIRTAZAPINE; MOOD STABILIZER; NEUROLEPTIC AGENT; NORTRIPTYLINE; OLANZAPINE; QUETIAPINE; VENLAFAXINE;

ADULT; AGE; ARTICLE; BIPOLAR DEPRESSION; CLINICAL TRIAL; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HAMILTON SCALE; HEADACHE; HUMAN; HYPOMANIA; MAJOR CLINICAL STUDY; MALE; NIGHTMARE; PREDICTOR VARIABLE; REMISSION; SOMNOLENCE; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT DURATION; AGED; BIPOLAR DISORDER; MAJOR DEPRESSION; MIDDLE AGED; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 77957086223     PISSN: 00223018     EISSN: None     Source Type: Journal    
DOI: 10.1097/NMD.0b013e3181ef2175     Document Type: Article

References (18)

1. Adli M, Baethge C, Heinz A, Langlitz N, Bauer M (2005) Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review. Eur Arch Psychiatry Clin Neurosci. 255:387-400.
2. APA (2000) Diagnostic and Statistic Manual of Mental Disorders. Arlington, VA: American Psychiatric Association.
3. Brunoni AR, Correa CF, Imamura M, Teng CT, Brasil-neto JP, Boeachat R, Rosa M, Caramelli P, Cohen RB, Del Porto JA, Boggio PS, Fregni F (2010) Neuromodulation approaches for the treatment of major depression: Challenges and recommendations from a working group meeting. Arq Neuropsiquiatr. 68:433-451.
4. Brunoni AR, Fraguas R, Fregni F (2009a) Pharmacological and combined interventions for the acute depressive episode: Focus on efficacy and tolerability. Ther Clin Risk Manag. 5:897-910.
5. Brunoni AR, Fregni F. Clinical trial design in noninvasive brain stimulation psychiatric research. Int J Methods Psychiatr Res. In press.
6. Brunoni AR, Lopes M, Kaptchuk TJ, Fregni F (2009b) Placebo response of non-pharmacological and pharmacological trials in major depression: A systematic review and meta-analysis. PLoS One. 4: e4824.
7. Dell'Osso B, Mundo E, D'urso N, Pozzoli S, Buoli M, Ciabatti M, Rosanova M, Massimini M, Bellina V, Mariotti M, Altamura AC (2009) Augmentative repetitive navigated transcranial magnetic stimulation (rTMS) in drug-resistant bipolar depression. Bipolar Disord. 11:76-81.
8. Fountoulakis KN, Grunze H, Panagiotidis P, Kaprinis G (2008) Treatment of bipolar depression: An update. J Affect Disord. 109:21-34.
9. Fregni F, Marcolin MA, Myczkowski M, Amiaz R, Hasey G, Rumi DO, Rosa M, Rigonatti SP, Camprodon J, Walpoth M, Heaslip J, Grunhaus L, Hausmann A, Pascual-Leone A (2006) Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation. Int J Neuropsychopharmacol. 9:641-654. (Pubitemid 46127397)
10. *D report. J Clin Psychiatry. 69:1246-1256.
11. Gitlin M (2006) Treatment-resistant bipolar disorder. Mol Psychiatry. 11:227-240.
12. Goldberg JF, Brooks JO III, Kurita K, Hoblyn JC, Ghaemi SN, Perlis RH, Miklowitz DJ, Ketter TA, Sachs GS, Thase ME (2009) Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: Findings from the STEP-BD. J Clin Psychiatry. 70:155-162.
13. Gross M, Nakamura L, Pascual-Leone A, Fregni F (2007) Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and meta-analysis comparing the recent versus the earlier rTMS studies. Acta Psychiatr Scand. 116:165-173.
14. Katon W, Unutzer J, Russo J (2010) Major depression: The importance of clinical characteristics and treatment response to prognosis. Depress Anxiety. 27:19-26.
15. Kennedy SH, Milev R, Giacobbe P, Ramasubbu R, Lam RW, Parikh SV, Patten SB, Ravindran AV (2009) Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies. J Affect Disord. 117: S44-S53.
16. Nahas Z, Kozel FA, Li X, Anderson B, George MS (2003) Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: A pilot study of acute safety and efficacy. Bipolar Disord. 5:40-47.
17. Perlis RH (2007) Treatment of bipolar disorder: The evolving role of atypical antipsychotics. Am J Manag Care. 13: S178-S188.
18. Schutter DJ (2009) Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: A meta-analysis. Psychol Med. 39:65-75.